涎腺癌
- 名Salivary gland carcinoma;carcinoma of salivary gland
-
涎腺癌DNA含量的流式细胞分析及其临床病理学意义
Flow cytometric DNA analysis of salivary gland carcinomas and clinicopathologic implications
-
这表明DNA倍体异常是涎腺癌的一个重要生物学特征,对于指示涎腺癌的生物学行为、指导治疗和判断预后具有一定的临床意义。
This indicates that abnormal cellular DNA content is an important biological characteristic of salivary gland carcinomas . The relationship between DNA ploidy and prognosis was not found .
-
涎腺癌及涎腺正常组织MDRlmRNA表达的研究
Expression of mdrl mRNA in normal salivary gland and its related carcinoma
-
survivin可能通过抑制涎腺癌的细胞凋亡,对涎腺癌的发生发展起重要作用;
Survivin possibly plays an important role in the occurrence and the development of salivary gland carcinoma .
-
目的:探讨阿霉素诱导人涎腺癌细胞凋亡过程中细胞游离Ca2+([Ca2+]i)和蛋白激酶C(PKC)浓度的变化特点和意义。
Objective : To study the significance of intracellular free calcium levels ( [ Ca 2 + ] I ) and protein kinase C ( PKC ) levels in the process of human salivary gland mucoepidermoid carcinoma MEC-1 cell apoptosis induced by adriamycin .
-
结果:涎腺癌肉瘤临床表现常为迅速增大的颜面部肿物并伴疼痛。
Results Initial symptoms of salivary carcinosarcoma were ache and tumidness of face .
-
本法对诊断口腔领面部鳞癌,涎腺癌有较高的阳性检出率,而且假阳性很低。
Histologically , higher positive rates were found in squamous carcinoma and salivary gland adenocarcinoma .
-
涎腺癌肉瘤临床及病理分析
Clinicopathological analysis of salivary carcinosarcoma
-
硬腭小涎腺癌的疗效评价和预后因素分析
Effectiveness Evaluation and Prognostic Factor Analysis in Patients with Minor Salivary Gland Carcinoma of the Hard Palate
-
150例涎腺癌3、5、10年生存率为80.7%、69.4%、52.1%。
The 3,5 and 10 year survival rates of these 150 patients were 80 . 7 % , 69 . 4 % . 52 . 1 % respectively .
-
目的通过对146例口腔癌及涎腺癌颈部淋巴组织清扫术进行临床分析,为选择合理的口腔癌及涎腺癌颈淋巴组织清扫术术式提供依据。
Objective To provide clinical basis for selecting rational approach for neck dissection of oral carcinomas ( OC ) and salivary gland carcinomas ( SGC ) by analyzing the neck dissection of 146 cases of OC and SGC .
-
背景与目的:硬腭小涎腺癌由于发病率低、长期生存率较高,使评价其治疗效果及预后因素较为困难。
BACKGROUND & OBJECTIVE : Minor salivary gland carcinoma of the hard palate is rare , and its long term survival rate is high , making it difficult to evaluate the prognostic factors and the efficacy of treatment .
-
术后放疗和化疗,对涎腺癌,生存率是重要的,涎腺癌复发率为27.6%,颈淋巴结转移率为9.2%。
Postoperative radiotherapy and chemotherapy may increase the survival rate of the patients with carcinoma of salivary glands . The overall recurrent rate was 27 . 6 % , the neck lymph node metastasis rate was 9.2 % .
-
涎腺腺癌COX-2表达和肿瘤血管生成的研究
Study of COX-2 expression and angiogenesis in salivary gland adenocarcinoma
-
MVD随着VEGF和iNOS表达的增强而增加,说明两者对涎腺腺癌血管生成具有促进作用。
The iNOS and the VEGF are associated with the angiogenesis of salivary adenocarcinoma .
-
目的探讨环氧合酶-2(COX-2)表达和涎腺腺癌血管生成的关系。
Objective To explore the relationship between COX-2 expression and angiogenesis in salivary gland adenocarcinoma .
-
结果PCNA在涎腺腺癌中的表达阳性率为(76.12±19.24)%,表达呈异质性。
Results The positive rates of PCNA expression in salivary glands adenocarcinoma tissue was 76.12 ± 19.24 % .
-
目的研究微血管密度(MVD)和血管内皮生长因子(VEGF)在涎腺腺癌中的表达,探讨其与预后关系。
Objective To evaluate the clinical significance of microvessel density ( MVD ) and vascular endothelial growth factor ( VEGF ) expression in salivary glands adenocarcinoma .
-
12例涎腺导管癌临床生物学特点及预后分析
Analysis of clinical-biological characteristics and prognosis of 12 salivary duct carcinoma
-
涎腺肌上皮癌6例报告
Myoepithelial Carcinoma of Salivary Glands . A Report of 6 Cases
-
涎腺肌上皮癌的生物学行为及治疗
The behaviour and treatment of myoepithelial carcinoma of salivary glands
-
13例涎腺腺癌的治疗与预后探讨
Study on the Therapy and Prognosis of 13 Cases of Salivary Adenocarcinoma
-
涎腺导管癌
Salivary duct carcinoma : An analysis of three cases with review of literature
-
涎腺导管癌临床病理和免疫组化研究
Salivary duct carcinoma clinicopathologic and immunohistochemical study
-
方法:本研究对6例涎腺导管癌进行临床病理分析。
Methods : This study was to investigate clinicopathological characteristic of 6 salivary duct carcinomas .
-
13例涎腺腺癌的临床分析
Clinical Analysis for Therapy and Prognosis of Adenocarcinoma Salivary Glands : A Report of 13 Cases
-
目的了解涎腺腺癌发病情况、构成特点,并探讨13例涎腺腺癌的治疗方式和治疗效果,指导临床实践。
Objective To investigate the clinical features , the operative type and therapeutic efficacy of salivary adenocarcinoma .
-
免疫组化研究对于判断涎腺导管癌早期局部复发、远处转移和生存率有所帮助。
Immunohistochemical study was linked to the early local disease recurrence , distant disease metastasis and survival rates .
-
提要作者回顾分析最近两年所诊治的涎腺导管癌资料,讨论了临床表现,组织病理学特征和治疗方法。
I the past two years , three cases of salivary duct carcinoma were treated and the clinical features , pathological characteristics and therapy were discussed .
-
结论:涎腺导管癌高度恶性,预后较差,治疗方法以局部彻底扩大切除,根治性颈清为主,术后辅以放疗和化疗。
Salivary duct carcinoma was high-grade malignancy and prognosis was bad . Conclusions : Complete local excision with radical neck dissection and postoperative radiation therapy seemed to offer the most potential for effective treatment .